Celebs opt for safer Breastox Botox

London – Bust-boosting surgery has never been more popular, with more than 300 000 boob job operations taking place worldwide every year. And that’s just the figure for registered operations.



But not everyone wants to go under the knife, including some of the A-list clients who visit medic Dr Nirdosh in the UK.

Instead of scalpels and implants, they are opting for a new treatment, which has been dubbed “the Botox boob job” and uses injectables to plump up the cleavage.

“The Breastox-Botox is fast becoming the must-have pre-red carpet procedure for my celebrity clients,” explains Dr Nirdosh.

“It is a knifeless instantaneous breast lift. This form of breast augmentation works best for those who are between a cup size A and C and is safer and quicker than regular surgery.”

The £1 000 (R17 563) treatment involves injecting Botox into the pectoral muscles, which temporarily relaxes them, leaving the shoulder and surrounding chest muscles to take the strain.

As a result, breasts are lifted and look higher and firmer, although given Botox wears off, the effect lasts for a maximum of six months.

“There’s no downtime, no reported side effects, no scars and it is virtually painless,” adds Dr Nirdosh.

“It takes less than 30 minutes and is the ideal treatment for women suffering from post-pregnancy droopy boobs, ageing, sagging breasts or a wrinkly bust line as a result of sun damage. It is also good if you want a bit of extra support so you can go braless, as many of my red carpet clients do.”

Traditional breast enhancement involves having a cut made either beneath the breasts or in the armpits and inserting a silicone implant between the breast tissue and the chest muscle.

Operations cost between £3 500 and £5 000 and, according to the health groups, complications can include infection, scarring and loss of sensation in the nipple.

Nevertheless, according to figures produced by the British Association of Aesthetic Surgeons (Baaps), breast implants still remain one of the most popular cosmetic surgeries.

But thanks to scandals such as the PIP implant saga, which saw women fitted with enhancements made with industrial, rather than medical grade silicone, many are turning to “safer” injectables .

Although Macrolane, a filler marketed as a “lunchtime boob jab” was withdrawn from sale two years ago following claims that 25 percent of patients suffered complications after the treatment, others have proved considerably less problematic.

Among them is Botox, which, according to the International Society of Aesthetic Plastic Surgeons, is the most popular non-surgical cosmetic treatment in the world.


The Botox boob job is working wonders for women


Celebrity plastic surgeon Dr  Nirdosh reveals that the Botox boob job has become popular among his high-end clients and that there’s less of a need to go under the knife to obtain fuller and perkier breasts. “It is a knifeless instantaneous breast lift. This form of breast augmentation works best for those who are between a cup size A and C and is safer and quicker than regular surgery,” told the DailyMail.

The procedure costs about $1,000 and takes 30 minutes to complete. Dr Nirdosh recommends the Botox boob job for moms who are looking to get their breasts back to their pre-baby era. As we know, Botox isn’t a permanent procedure. Women will have to go in several times a year to maintain their enhanced breasts.

PIP Breast Implant founder Jean-Claude Mas released from custody


With over 13,000 French women alone and thousands around the world having undergone cosmetic surgery to remove the rupture prone PIP breast implants, it comes as a surprise to many that PIP founder Jean-Claude Mas is released from custody. Having spent the last eight months behind bars, he is now due for trial later in the year.


French government scientists found that Mr Mas’ implants contained the chemicals baysilone, silopren and rhodorsil – normally used as fuel additives or in the manufacture of industrial rubber tubing. He has reportedly confessed to illegally obtaining the low-cost gel but denies that the PIP implants posed a threat to health. Studies showed that the sub-standard silicone used posed no serious long-term threats to health, but the PIP products were up to twice as likely to burst as other implants.

Worldwide it has been reported that over 400,000 women have PIP implants and in the UK 40, 000 women alone have PIP breast implants. The company was placed into liquidation when the true nature of the business was disclosed.  In December 2011, the government advised women to have the implants removed, “even without clinical signs of a deterioration of the implant,” saying they presented an unusually high rupture risk and that the leaked silicone could cause irritation.

Mr Mas is due to go on trial in April 2013. This will be a major worldwide trail which involves up to 180 lawyers as 4,600 complaints come forward.